Good evening :)
Place Order
Add to Watchlist

Zota Health Care Ltd

ZOTA

Zota Health Care Ltd

ZOTA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,218 cr, stock is ranked 1,095
Moderate RiskStock is 2.87x as volatile as Nifty
836.201.03% (+8.50)
836.201.03% (+8.50)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,218 cr, stock is ranked 1,095
Moderate RiskStock is 2.87x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,218 cr, stock is ranked 1,095
Moderate RiskStock is 2.87x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-63.9824.660.12%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Zota Health Care Ltd. is a pharmaceutical company engaged in the business of manufacturing and marketing of medicines

Investor Presentation

View older 

Nov 26, 2024

PDF
View Older Presentations

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.84%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.04% to 0.05%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue87.1096.59109.08132.82142.45181.65221.31
Raw Materialssubtract64.2759.5775.8886.6799.41108.83220.43
Power & Fuel Costsubtract0.540.600.700.891.272.18
Employee Costsubtract8.029.598.589.5212.1929.33
Selling & Administrative Expensessubtract10.1911.8021.4717.2534.5541.47
Operating & Other expensessubtract-5.209.01-0.462.06-14.79-8.88
Depreciation/Amortizationsubtract1.392.103.173.6711.9620.0929.41
Interest & Other Itemssubtract0.040.070.110.322.564.798.57
Taxes & Other Itemssubtract2.311.12-0.153.531.08-1.81-2.42
EPS1.610.93-0.093.58-2.30-5.63-13.42
DPS0.711.001.001.501.001.001.00
Payout ratio0.441.08—0.42——-0.07
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual Report Unavailable

Investor Presentation

Jun 29PDF
FY 2022

Annual Report Unavailable

Investor Presentation

Jun 10PDF
Feb 17PDF
Dec 27PDF
Aug 2PDF
FY 2023

Annual Report Unavailable

Investor Presentation

Jun 26PDF
Feb 16PDF
Nov 22PDF
Sep 17PDF
FY 2024

Annual Report Unavailable

FY 2025

Annual Report Pending

Investor Presentation

Nov 26PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Zota Health Care Ltd-154.6224.660.12%
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57—

Price Comparison

Compare ZOTA with any stock or ETF
Compare ZOTA with any stock or ETF
ZOTA
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.75%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding62.40%0.00%0.99%0.01%36.60%

Apr 2024

Jun 2024

Aug 2024

Sep 2024

Shareholding History

Dec '23MarAprJunAugSep0.00%0.00%0.00%0.01%0.02%0.01%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ZOTA has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.12%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.18 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 20, 2024

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateSep 19, 2022

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 19, 2022

Cash Dividend

Ex DateEx DateSep 22, 2021

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 22, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 17, 2020

News & Opinions
Earnings
Zota Health Care reports consolidated net loss of Rs 12.10 crore in the September 2024 quarter

Net Loss of Zota Health Care reported to Rs 12.10 crore in the quarter ended September 2024 as against net loss of Rs 1.65 crore during the previous quarter ended September 2023. Sales rose 48.62% to Rs 67.28 crore in the quarter ended September 2024 as against Rs 45.27 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales67.2845.27 49 OPM %-1.299.76 - PBDT-3.183.69 PL PBT-12.69-1.11 -1043 NP-12.10-1.65 -633 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Zota Health Care to discuss results

Zota Health Care will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Zota Health Care AGM scheduled

Zota Health Care announced that the 24th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Zota Health Care reports consolidated net loss of Rs 12.72 crore in the June 2024 quarter

Net Loss of Zota Health Care reported to Rs 12.72 crore in the quarter ended June 2024 as against net loss of Rs 2.84 crore during the previous quarter ended June 2023. Sales rose 45.67% to Rs 56.30 crore in the quarter ended June 2024 as against Rs 38.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales56.3038.65 46 OPM %-2.243.31 - PBDT-4.140.60 PL PBT-12.16-2.81 -333 NP-12.72-2.84 -348 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Zota Health Care to announce Quarterly Result

Zota Health Care will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live
NEWSMAKERS Talk Show | In conversation with Dr. Sujit Paul, Group CEO - Zota Healthcare (Dava India)
8 months agoMint

Zota Health Care consolidated net profit declines 71.65% in the September 2022 quarter

2 years agoBusiness Standard

Zota Health Care reports consolidated net loss of Rs 0.82 crore in the June 2022 quarter

2 years agoBusiness Standard

Zota Healthcare’s ‘Corovyl’ successfully clears second phase of clinical study; Stock up 2.5%

3 years agoIndia Infoline

Zota Health Care standalone net profit rises 225.49% in the September 2021 quarter

3 years agoBusiness Standard